SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (2260)1/25/2001 6:31:05 PM
From: nigel batesRead Replies (1) of 4974
 
Jan. 25, 2001--Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN - news) announced that it filed a registration statement with the Securities and Exchange Commission for a proposed offering by the Company of 4,000,000 shares of the Company's common stock, with an additional 600,000 shares available to cover an over-allotment option. The public offering is being underwritten by Merrill Lynch & Co., JP Morgan, and Robertson Stephens....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News